Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis Via Warburg Effect

Overview

Journal Adv Pharm Bull

Date 2022 Aug 8

PMID 35935051

Authors

Anjali Kandiruthi Ravi

Saradhadevi Kuppusami Muthukrishnan

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). It is an auto-immune disorder. Its usual symptoms are unique to each person. In MS lesions vast fractions of pyruvate molecules are instantly transformed into lactate. This reprogramming mechanism of glycolysis is known as the Warburg effect. MS has no efficient treatment yet. Hence, there is a requirement for profitable immunomodulatory agents in MS. Probiotics perform as an immunomodulator because they regulate the host's immune responses. Its efficacy gets enhanced for an extended period when it combines with prebiotics. In this review, we focus on the metabolic alterations behind the MS lesions via the Warburg effect, and also suggesting, the combined efficacy of prebiotics and probiotics for the effective treatment of MS without side effects. The Warburg effect mechanism intensifies the infiltration of activated T-cells and B-cells into the CNS. It provokes the inflammation process on the myelin sheath. The infiltration of immune cells can be inhibited by the combination therapy of probiotics and prebiotics. By this review, we can recommend that the idea of this combinational therapy can do miracles in the treatment of MS in the future.

Citing Articles

Surfeit 4 regulates aerobic glycolysis to enhanced proliferation, tumor stemness, invasion, and metastasis in oral squamous cell carcinoma.

Yuan W, Tan T, Lu L, Lu C, Zhang Y, Liu B Cytojournal. 2024; 21:60.

PMID: 39737129 PMC: 11683412. DOI: 10.25259/Cytojournal_137_2024.

Targeting Lactate: An Emerging Strategy for Macrophage Regulation in Chronic Inflammation and Cancer.

Jiang R, Ren W, Wang L, Zhang W, Jiang Z, Zhu G Biomolecules. 2024; 14(10).

PMID: 39456135 PMC: 11505598. DOI: 10.3390/biom14101202.

The Impact of Microbiota-Immunity-Hormone Interactions on Autoimmune Diseases and Infection.

Martinelli S, Nannini G, Cianchi F, Coratti F, Amedei A Biomedicines. 2024; 12(3).

PMID: 38540229 PMC: 10967803. DOI: 10.3390/biomedicines12030616.

References

Chae C, Kwon H, Hwang J, Kim J, Im S . Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis. PLoS One. 2013; 7(12):e52119. PMC: 3527378. DOI: 10.1371/journal.pone.0052119. View

Schocke M, Berger T, Felber S, Wolf C, Deisenhammer F, Kremser C . Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy. Neuroimage. 2003; 20(2):1253-63. DOI: 10.1016/S1053-8119(03)00409-9. View

Mohajeri M, Sadeghizadeh M, Najafi F, Javan M . Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Neuropharmacology. 2015; 99:156-67. DOI: 10.1016/j.neuropharm.2015.07.013. View

Loch-Neckel G, Koepp J . [The blood-brain barrier and drug delivery in the central nervous system]. Rev Neurol. 2010; 51(3):165-74. View

Giacoppo S, Pollastro F, Grassi G, Bramanti P, Mazzon E . Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Fitoterapia. 2016; 116:77-84. DOI: 10.1016/j.fitote.2016.11.010. View

Koch-Henriksen N, Soelberg Sorensen P . The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010; 9(5):520-32. DOI: 10.1016/S1474-4422(10)70064-8. View

Zaheer S, Wu Y, Bassett J, Yang B, Zaheer A . Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis. Neurochem Res. 2007; 32(12):2123-31. DOI: 10.1007/s11064-007-9383-0. View

Krawczyk C, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis R . Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010; 115(23):4742-9. PMC: 2890190. DOI: 10.1182/blood-2009-10-249540. View

Comabella M, Lunemann J, Rio J, Sanchez A, Lopez C, Julia E . A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain. 2009; 132(Pt 12):3353-65. DOI: 10.1093/brain/awp228. View

10.

Ghaffari S, Hatami H, Dehghan G . Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide. Res Pharm Sci. 2015; 10(3):222-32. PMC: 4621629. View

11.

Ngo D, Ververis K, Tortorella S, Karagiannis T . Introduction to the molecular basis of cancer metabolism and the Warburg effect. Mol Biol Rep. 2015; 42(4):819-23. DOI: 10.1007/s11033-015-3857-y. View

12.

Dargahi N, Matsoukas J, Apostolopoulos V . ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice. Brain Sci. 2020; 10(2). PMC: 7071487. DOI: 10.3390/brainsci10020126. View

13.

Kawai T, Akira S . Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007; 13(11):460-9. DOI: 10.1016/j.molmed.2007.09.002. View

14.

Tankou S, Regev K, Healy B, Cox L, Tjon E, Kivisakk P . Investigation of probiotics in multiple sclerosis. Mult Scler. 2018; 24(1):58-63. DOI: 10.1177/1352458517737390. View

15.

Ozenci V, Kouwenhoven M, Huang Y, Kivisakk P, Link H . Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin Exp Immunol. 2000; 120(1):147-53. PMC: 1905623. DOI: 10.1046/j.1365-2249.2000.01175.x. View

16.

Pfeiffer T, Schuster S, Bonhoeffer S . Cooperation and competition in the evolution of ATP-producing pathways. Science. 2001; 292(5516):504-7. DOI: 10.1126/science.1058079. View

17.

Thompson C . Wnt meets Warburg: another piece in the puzzle?. EMBO J. 2014; 33(13):1420-2. PMC: 4194084. DOI: 10.15252/embj.201488785. View

18.

Arellano G, Ottum P, Reyes L, Burgos P, Naves R . Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front Immunol. 2015; 6:492. PMC: 4586507. DOI: 10.3389/fimmu.2015.00492. View

19.

Baumann N, Pham-Dinh D . Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001; 81(2):871-927. DOI: 10.1152/physrev.2001.81.2.871. View

20.

Jangi S, Gandhi R, Cox L, Li N, von Glehn F, Yan R . Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016; 7:12015. PMC: 4931233. DOI: 10.1038/ncomms12015. View